Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
335 Towards an implantable replenishable delivery device for natural killer cell and Tri-specific killer engager antibodies to the intraperitoneal space to treat ovarian cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
